Insider Stock Trading History of Hanson Gregory P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hanson Gregory P since year 2005. The trader's CIK number is 1186120. At the time of this reporting, Hanson Gregory P is the CHIEF FINANCIAL OFFICER, SECR of Mabvax Therapeutics Holdings, Inc. . (stock ticker symbol MBVX). See this page for all insider trading activities at Mabvax Therapeutics Holdings, Inc. .

Note that in the past HANSON GREGORY P also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hanson Gregory P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-04-02 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 7,021 .00 0
2018-01-16 MBVX Mabvax Therapeutics Holdings, Inc. Sale 41,873 .92 38,523
2018-01-08 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 449,159 .00 0
2018-01-10 MBVX Mabvax Therapeutics Holdings, Inc. Sale 66,550 .96 63,888
2018-01-11 MBVX Mabvax Therapeutics Holdings, Inc. Sale 38,697 .98 37,923
2018-01-12 MBVX Mabvax Therapeutics Holdings, Inc. Sale 11,232 .96 10,782
2017-05-19 MBVX Mabvax Therapeutics Holdings, Inc. Buy 9,128 .88 7,987
2017-04-12 MBVX Mabvax Therapeutics Holdings, Inc. Sale 3,885 2.00 7,770
2017-04-07 MBVX Mabvax Therapeutics Holdings, Inc. Sale 450 2.00 902
2017-04-10 MBVX Mabvax Therapeutics Holdings, Inc. Sale 400 2.00 800
2017-04-11 MBVX Mabvax Therapeutics Holdings, Inc. Sale 200 2.00 400
2017-04-04 MBVX Mabvax Therapeutics Holdings, Inc. Sale 1,000 2.25 2,250
2017-04-05 MBVX Mabvax Therapeutics Holdings, Inc. Sale 1,800 2.15 3,871
2017-04-06 MBVX Mabvax Therapeutics Holdings, Inc. Sale 867 2.15 1,862
2017-04-02 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 21,064 .00 0
2016-08-17 MBVX Mabvax Therapeutics Holdings, Inc. Buy 3,119 .00 0
2016-04-04 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 155,867 .00 0
2014-12-16 MBVX Mabvax Therapeutics Holdings, Inc. Buy 3,000 2.50 7,500
2006-05-26 AVNR Avanir Pharmaceuticals Buy 1,100 9.67 10,639

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR of Mabvax Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.